{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:30:29Z","timestamp":1790857829415,"version":"4.1.0"},"reference-count":209,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.pharmthera.2020.107474","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T11:27:01Z","timestamp":1578569221000},"page":"107474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"special_numbering":"C","title":["Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis"],"prefix":"10.1016","volume":"208","author":[{"given":"Andras","family":"Garami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury P.","family":"Shimansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Rumbus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson C.L.","family":"Vizin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelli","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Szakacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Solymar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Csenkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan A.","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade D.","family":"Van Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej A.","family":"Romanovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107474_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2009.10.005","article-title":"The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation","volume":"125","author":"Alawi","year":"2010","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0010","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1096\/fj.15-272526","article-title":"The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature","volume":"29","author":"Alawi","year":"2015","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0015","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.5606-11.2012","article-title":"Pharmacological blockade of the cold receptor TRPM8 attenuates autonomic and behavioral cold defenses and decreases deep body temperature","volume":"32","author":"Almeida","year":"2012","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0020","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.3390\/md11125100","article-title":"Polypeptide modulators of TRPV1 produce analgesia without hyperthermia","volume":"11","author":"Andreev","year":"2013","journal-title":"Marine Drugs"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0030","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1097\/j.pain.0000000000000610","article-title":"A randomized, double-blind, positive-controlled, 3-way cross-over human experimental pain study of a TRPV1 antagonist (V116517) in healthy volunteers and comparison with preclinical profile","volume":"157","author":"Arendt-Nielsen","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0035","doi-asserted-by":"crossref","DOI":"10.1097\/PR9.0000000000000696","article-title":"NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain","volume":"3","author":"Arsenault","year":"2018","journal-title":"Pain Reports"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1113\/jphysiol.1996.sp021618","article-title":"Effect of muscle acidity on muscle metabolism and fatigue during intense exercise in man","volume":"495","author":"Bangsbo","year":"1996","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.5414\/CP201890","article-title":"The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis","volume":"51","author":"Bareille","year":"2013","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0055","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1164\/rccm.201704-0769OC","article-title":"XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough","volume":"196","author":"Belvisi","year":"2017","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0060","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1167\/iovs.16-20303","article-title":"Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease","volume":"57","author":"Benitez-Del-Castillo","year":"2016","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0070","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2174\/156802611796904825","article-title":"TRPV1 activation is not an all-or-none event: TRPV1 partial agonism\/antagonism and its regulatory modulation","volume":"11","author":"Blumberg","year":"2011","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0075","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.cell.2010.03.052","article-title":"A bivalent tarantula toxin activates the capsaicin receptor, TRPV1, by targeting the outer pore domain","volume":"141","author":"Bohlen","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0080","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1210\/jc.2006-1438","article-title":"Water drinking induces thermogenesis through osmosensitive mechanisms","volume":"92","author":"Boschmann","year":"2007","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0085","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbamcr.2012.11.017","article-title":"Protons stabilize the closed conformation of gain-of-function mutants of the TRPV1 channel","volume":"1833","author":"Boukalova","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/cells3020517","article-title":"TRPV1: A potential drug target for treating various diseases","volume":"3","author":"Brito","year":"2014","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0095","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jpain.2017.01.009","article-title":"Safety, pharmacokinetics, and pharmacodynamics study in healthy subjects of oral NEO6860, a modality selective transient receptor potential vanilloid subtype 1 antagonist","volume":"18","author":"Brown","year":"2017","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pharmthera.2004.11.008","article-title":"Contribution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions","volume":"106","author":"Calixto","year":"2005","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neuron.2012.12.016","article-title":"TRPV1 channels are intrinsically heat sensitive and negatively regulated by phosphoinositide lipids","volume":"77","author":"Cao","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature12823","article-title":"TRPV1 structures in distinct conformations reveal activation mechanisms","volume":"504","author":"Cao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00003677-200407000-00005","article-title":"Multiple triggers for hyperthermic fatigue and exhaustion","volume":"32","author":"Cheung","year":"2004","journal-title":"Exercise and Sport Sciences Reviews"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2007.06.006","article-title":"The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans","volume":"132","author":"Chizh","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cns.12770","article-title":"Inhibition of transient potential receptor vanilloid type 1 suppresses seizure susceptibility in the genetically epilepsy-prone rat","volume":"24","author":"Cho","year":"2018","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/ph9040066","article-title":"Use of capsaicin to treat pain: mechanistic and therapeutic considerations","volume":"9","author":"Chung","year":"2016","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0150","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1006\/bbrc.2001.4482","article-title":"The tissue distribution and functional characterization of human VR1","volume":"281","author":"Cortright","year":"2001","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0155","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/0024-3205(92)90046-R","article-title":"Treatment parameters of desensitization to capsaicin","volume":"51","author":"Craft","year":"1992","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1085\/jgp.201110724","article-title":"Selective disruption of high sensitivity heat activation but not capsaicin activation of TRPV1 channels by pore turret mutations","volume":"139","author":"Cui","year":"2012","journal-title":"The Journal of General Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0170","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1523\/JNEUROSCI.0793-06.2006","article-title":"Prolactin modulates TRPV1 in female rat trigeminal sensory neurons","volume":"26","author":"Diogenes","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0175","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.bjp.0705977","article-title":"Lipopolysaccharide fever is initiated via a capsaicin-sensitive mechanism independent of the subtype-1 vanilloid receptor","volume":"143","author":"Dogan","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13054-3","article-title":"Reactive metabolites of acetaminophen activate and sensitize the capsaicin receptor TRPV1","volume":"7","author":"Eberhardt","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2013.03.012","article-title":"Acetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2","volume":"71","author":"Engstrom Ruud","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0195","author":"Evans"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0200","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/23328940.2015.1024383","article-title":"Induction of therapeutic hypothermia by pharmacological modulation of temperature-sensitive TRP channels: Theoretical framework and practical considerations","volume":"2","author":"Feketa","year":"2015","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature17964","article-title":"TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action","volume":"534","author":"Gao","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/ALN.0000000000001812","article-title":"Transient receptor potential vanilloid 1 antagonists prevent anesthesia-induced hypothermia and decrease postincisional opioid dose requirements in rodents","volume":"127","author":"Garami","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13038","article-title":"TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: compounds\u2019 pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development","volume":"223","author":"Garami","year":"2018","journal-title":"Acta Physiologica (Oxford)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0220","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1523\/JNEUROSCI.4671-10.2011","article-title":"Thermoregulatory phenotype of the Trpv1 knockout mouse: Thermoeffector dysbalance with hyperkinesis","volume":"31","author":"Garami","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0225","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1523\/JNEUROSCI.5150-09.2010","article-title":"Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia","volume":"30","author":"Garami","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/B978-0-444-64074-1.00034-3","article-title":"Fever and hypothermia in systemic inflammation","volume":"157","author":"Garami","year":"2018","journal-title":"Handbook of Clinical Neurology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0235","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/23328940.2019.1607490","article-title":"What is new about mild temperature sensing? A review of recent findings","volume":"6","author":"Garcia-Avila","year":"2019","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.107.125674","article-title":"Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade","volume":"323","author":"Gavva","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0245","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1523\/JNEUROSCI.4833-06.2007","article-title":"The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation","volume":"27","author":"Gavva","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0250","doi-asserted-by":"crossref","first-page":"20283","DOI":"10.1074\/jbc.M312577200","article-title":"Molecular determinants of vanilloid sensitivity in TRPV1","volume":"279","author":"Gavva","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0260","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2008.01.024","article-title":"Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans","volume":"136","author":"Gavva","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0265","author":"Gomtsian"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0270","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/23328940.2015.1046013","article-title":"TRPV1 ligands with hyperthermic, hypothermic and no temperature effects in rats","volume":"2","author":"Gomtsyan","year":"2015","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0275","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature10245","article-title":"Ganglion-specific splicing of TRPV1 underlies infrared sensation in vampire bats","volume":"476","author":"Gracheva","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0280","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/medsci7080082","article-title":"TRPV1 antagonists as novel anti-diabetic agents: regulation of oral glucose tolerance and insulin secretion through reduction of low-grade inflammation?","volume":"7","author":"Gram","year":"2019","journal-title":"Medical Sciences (Basel)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0285","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.molmed.2017.09.005","article-title":"TRPV1: a potential therapeutic target in type 2 diabetes and comorbidities?","volume":"23","author":"Gram","year":"2017","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0290","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1210\/jc.2014-2282","article-title":"Elevated peritoneal expression and estrogen regulation of nociceptive ion channels in endometriosis","volume":"99","author":"Greaves","year":"2014","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0295","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1124\/jpet.106.116657","article-title":"Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1\/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor","volume":"321","author":"Gunthorpe","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0300","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1021\/acs.accounts.9b00075","article-title":"Structural and evolutionary insights point to allosteric regulation of TRP ion channels","volume":"52","author":"Hilton","year":"2019","journal-title":"Accounts of Chemical Research"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0305","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/acs.biochem.5b00071","article-title":"Understanding thermosensitive transient receptor potential channels as versatile polymodal cellular sensors","volume":"54","author":"Hilton","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0310","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(25)06664-5","article-title":"Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons","volume":"43","author":"Holzer","year":"1991","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0315","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/bjp.2008.351","article-title":"The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor","volume":"155","author":"Holzer","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0320","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-3-540-79090-7_9","article-title":"Acid-sensitive ion channels and receptors","author":"Holzer","year":"2009","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pain.2008.11.004","article-title":"Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia","volume":"142","author":"Honore","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0330","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2741\/1383","article-title":"Prostaglandin E2 as a mediator of fever: synthesis and catabolism","volume":"9","author":"Ivanov","year":"2004","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0340","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/23328940.2015.1045683","article-title":"The foundation of sensory pharmacology: Nicholas (Miklos) Jancso and the Szeged contribution","volume":"2","author":"Jancso","year":"2015","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0345","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s12272-012-1016-8","article-title":"Quantitative analysis of TRP channel genes in mouse organs","volume":"35","author":"Jang","year":"2012","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0350","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13356","article-title":"An external sodium ion binding site controls allosteric gating in TRPV1 channels","volume":"5","author":"Jara-Oseguera","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0355","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1460-9568.2005.04227.x","article-title":"Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naive, carrageenan-inflamed and neuropathic rats","volume":"22","author":"Jhaveri","year":"2005","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0360","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/toxsci\/kfi292","article-title":"TRPV1 antagonists elevate cell surface populations of receptor protein and exacerbate TRPV1-mediated toxicities in human lung epithelial cells","volume":"89","author":"Johansen","year":"2006","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0370","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0092-8674(02)00637-2","article-title":"Molecular basis for species-specific sensitivity to \u201chot\u201d chili peppers","volume":"108","author":"Jordt","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0375","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.1073\/pnas.100129497","article-title":"Acid potentiation of the capsaicin receptor determined by a key extracellular site","volume":"97","author":"Jordt","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0390","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1111\/bph.12414","article-title":"Transient receptor potential (TRP) channels: a clinical perspective","volume":"171","author":"Kaneko","year":"2014","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0400","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2014.01.038","article-title":"Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial","volume":"134","author":"Khalid","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0405","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1271\/bbb.61.1718","article-title":"Increase in swimming endurance capacity of mice by capsaicin-induced adrenal catecholamine secretion","volume":"61","author":"Kim","year":"1997","journal-title":"Bioscience, Biotechnology, and Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0410","first-page":"711499","article-title":"Evidence that the TRPV1 S1-S4 membrane domain contributes to thermosensing","author":"Kim","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0425","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1365-2036.2011.04629.x","article-title":"Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain","volume":"33","author":"Krarup","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0430","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/00365521.2012.758769","article-title":"Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain","volume":"48","author":"Krarup","year":"2013","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0435","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/13543776.16.7.977","article-title":"TRPV1 antagonists: a survey of the patent literature","volume":"16","author":"Kyle","year":"2006","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0440","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1113\/jphysiol.2006.116301","article-title":"Cardiovascular and temperature changes in spinal cord injured rats at rest and during autonomic dysreflexia","volume":"577","author":"Laird","year":"2006","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0445","doi-asserted-by":"crossref","first-page":"11342","DOI":"10.1073\/pnas.1604269113","article-title":"Low-cost functional plasticity of TRPV1 supports heat tolerance in squirrels and camels","volume":"113","author":"Laursen","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0450","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2147\/DDDT.S128727","article-title":"A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers","volume":"11","author":"Lee","year":"2017","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0455","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/13543776.2015.1008449","article-title":"Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014)","volume":"25","author":"Lee","year":"2015","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0460","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuroscience.2005.12.020","article-title":"The role of the capsaicin receptor TRPV1 and acid-sensing ion channels (ASICS) in proton sensitivity of subpopulations of primary nociceptive neurons in rats and mice","volume":"139","author":"Leffler","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0465","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.107.132233","article-title":"Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluorom ethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats","volume":"326","author":"Lehto","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0470","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature12822","article-title":"Structure of the TRPV1 ion channel determined by electron cryo-microscopy","volume":"504","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0475","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/cr.2011.205","article-title":"TRPV1 activation improves exercise endurance and energy metabolism through PGC-1alpha upregulation in mice","volume":"22","author":"Luo","year":"2012","journal-title":"Cell Research"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0490","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1746-6148-8-185","article-title":"Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis","volume":"8","author":"Malek","year":"2012","journal-title":"BMC Veterinary Research"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0495","doi-asserted-by":"crossref","DOI":"10.1097\/PR9.0000000000000576","article-title":"TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study","volume":"1","author":"Manitpisitkul","year":"2016","journal-title":"Pain Reports"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0500","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/sjpain-2017-0184","article-title":"A multiple-dose double-blind randomized study to evaluate the safety, pharmacokinetics, pharmacodynamics and analgesic efficacy of the TRPV1 antagonist JNJ-39439335 (mavatrep)","volume":"18","author":"Manitpisitkul","year":"2018","journal-title":"Scandinavian Journal of Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0505","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40261-015-0285-7","article-title":"Safety, tolerability and pharmacokinetic and pharmacodynamic learnings from a double-blind, randomized, placebo-controlled, sequential group first-in-human study of the TRPV1 antagonist, JNJ-38893777, in healthy men","volume":"35","author":"Manitpisitkul","year":"2015","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0510","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/cpdd.413","article-title":"Pharmacokinetics and safety of mavatrep (JNJ-39439335), a TRPV1 antagonist in healthy Japanese and Caucasian men: a double-blind, randomized, placebo-controlled, sequential-group phase 1 study","volume":"7","author":"Manitpisitkul","year":"2018","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0515","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cpdd.412","article-title":"Bioavailability and pharmacokinetics of TRPV1 antagonist mavatrep (JNJ-39439335) tablet and capsule formulations in healthy men: two open-label, crossover, single-dose phase 1 studies","volume":"7","author":"Manitpisitkul","year":"2018","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0520","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.sjpain.2017.07.021","article-title":"A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis","volume":"17","author":"Mayorga","year":"2017","journal-title":"Scandinavian Journal of Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0530","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1152\/jn.00560.2005","article-title":"Systemic and site-specific effects of A-425619, a selective TRPV1 receptor antagonist, on wide dynamic range neurons in CFA-treated and uninjured rats","volume":"95","author":"McGaraughty","year":"2006","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0535","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2009.02.018","article-title":"Antagonism of TRPV1 receptors indirectly modulates activity of thermoregulatory neurons in the medial preoptic area of rats","volume":"1268","author":"McGaraughty","year":"2009","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0540","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/sj.bjp.0703918","article-title":"Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)","volume":"132","author":"McIntyre","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0545","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cct.2013.12.007","article-title":"Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis","volume":"37","author":"Miller","year":"2014","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0550","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuroscience.2008.06.069","article-title":"Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat","volume":"156","author":"Mills","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0555","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1096\/fj.201800272R","article-title":"The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1-mediated hypothermia and is associated with prostaglandin inhibition in the brain","volume":"32","author":"Mirrasekhian","year":"2018","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0565","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1744-8069-1-35","article-title":"ASIC3, an acid-sensing ion channel, is expressed in metaboreceptive sensory neurons","volume":"1","author":"Molliver","year":"2005","journal-title":"Molecular Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0570","doi-asserted-by":"crossref","first-page":"16901","DOI":"10.1073\/pnas.1412689111","article-title":"Human TRPA1 is intrinsically cold- and chemosensitive with and without its N-terminal ankyrin repeat domain","volume":"111","author":"Moparthi","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0575","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/bph.14044","article-title":"Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field","volume":"175","author":"Moran","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0580","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1152\/japplphysiol.01227.2010","article-title":"2010 Carl Ludwig distinguished lectureship of the APS neural control and autonomic regulation section: central neural pathways for thermoregulatory cold defense","volume":"110","author":"Morrison","year":"2011","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0585","author":"Myers"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0590","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0167-0115(00)00193-2","article-title":"Comparison of currents activated by noxious heat in rat and chicken primary sensory neurons","volume":"96","author":"Nagy","year":"2000","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0600","author":"NCT01688934 ClinicalTrials.gov"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0605","author":"NCT01688947 ClinicalTrials.gov"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/112_2013_11","article-title":"Spices: the savory and beneficial science of pungency","volume":"164","author":"Nilius","year":"2013","journal-title":"Reviews of Physiology, Biochemistry and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0620","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/pr.113.008268","article-title":"Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine","volume":"66","author":"Nilius","year":"2014","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0630","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.1073\/pnas.1337252100","article-title":"Structural determinant of TRPV1 desensitization interacts with calmodulin","volume":"100","author":"Numazaki","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0635","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/j.2040-4603.2014.tb00554.x","article-title":"Performance in the heat-physiological factors of importance for hyperthermia-induced fatigue","volume":"4","author":"Nybo","year":"2014","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0640","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1079\/BJN2003919","article-title":"Dose-dependent effect of capsaicin on endurance capacity in rats","volume":"90","author":"Oh","year":"2003","journal-title":"British Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0645","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ALN.0000000000001700","article-title":"Acetaminophen metabolite N-acylphenolamine induces analgesia via transient receptor potential vanilloid 1 receptors expressed on the primary afferent terminals of C-fibers in the spinal dorsal horn","volume":"127","author":"Ohashi","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0650","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.bmc.2018.06.001","article-title":"Design, synthesis, and biological evaluation of novel biphenyl-4-carboxamide derivatives as orally available TRPV1 antagonists","volume":"26","author":"Oka","year":"2018","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0655","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1523\/JNEUROSCI.5387-13.2014","article-title":"Transient receptor potential channel ankyrin-1 is not a cold sensor for autonomic thermoregulation in rodents","volume":"34","author":"de Oliveira","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0660","first-page":"E1657","article-title":"TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain","volume":"115","author":"Ortiz-Renteria","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0665","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1113\/jphysiol.2001.013475","article-title":"Vago-sympathoadrenal reflex in thermogenesis induced by osmotic stimulation of the intestines in the rat","volume":"540","author":"Osaka","year":"2002","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0670","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1365-2125.2012.04405.x","article-title":"Effects of the TRPV1 antagonist ABT-102 on body temperature in healthy volunteers: pharmacokinetic\/ pharmacodynamic analysis of three phase 1 trials","volume":"75","author":"Othman","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0690","first-page":"R173","article-title":"The good enough calculi of evolving control systems: evolution is not engineering","volume":"242","author":"Partridge","year":"1982","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0700","author":"Patwardhan"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0705","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1210\/en.2017-00101","article-title":"Estradiol sensitizes the transient receptor potential vanilloid 1 receptor in pain responses","volume":"158","author":"Payrits","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0710","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/09680519050110050201","article-title":"Effects of perineural capsaicin treatment of the abdominal vagus on endotoxin fever and on a non-febrile thermoregulatory event","volume":"11","author":"Petervari","year":"2005","journal-title":"Journal of Endotoxin Research"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0715","doi-asserted-by":"crossref","first-page":"17165","DOI":"10.1074\/jbc.M313328200","article-title":"Identification of species-specific determinants of the action of the antagonist capsazepine and the agonist PPAHV on TRPV1","volume":"279","author":"Phillips","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0725","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.pain.2013.02.004","article-title":"TRPV1 antagonistic analgesic effect: a randomized study of AZD1386 in pain after third molar extraction","volume":"154","author":"Quiding","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0730","first-page":"822","article-title":"Effects of opioids, cannabinoids, and vanilloids on body temperature","volume":"3","author":"Rawls","year":"2011","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0735","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.111.190314","article-title":"Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature","volume":"342","author":"Reilly","year":"2012","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0745","doi-asserted-by":"crossref","first-page":"R502","DOI":"10.1152\/ajpregu.00114.2004","article-title":"Biochemistry of exercise-induced metabolic acidosis","volume":"287","author":"Robergs","year":"2004","journal-title":"American Journal of Physiology \u2013 Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0750","doi-asserted-by":"crossref","DOI":"10.1038\/srep36740","article-title":"Lactate is a potent inhibitor of the capsaicin receptor TRPV1","volume":"6","author":"de la Roche","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0755","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/apha.12231","article-title":"Skin temperature: its role in thermoregulation","volume":"210","author":"Romanovsky","year":"2014","journal-title":"Acta Physiologica (Oxford)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0760","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/23328940.2015.1047078","article-title":"Protecting western redcedar from deer browsing-with a passing reference to TRP channels","volume":"2","author":"Romanovsky","year":"2015","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0765","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-63912-7.00001-1","article-title":"The thermoregulation system and how it works","volume":"156","author":"Romanovsky","year":"2018","journal-title":"Handbook of Clinical Neurology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0770","author":"Romanovsky"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0775","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/pr.109.001263","article-title":"The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not","volume":"61","author":"Romanovsky","year":"2009","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0780","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1085\/jgp.200308906","article-title":"Ca2+\/calmodulin modulates TRPV1 activation by capsaicin","volume":"123","author":"Rosenbaum","year":"2004","journal-title":"The Journal of General Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0785","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2125.2011.04040.x","article-title":"An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects","volume":"72","author":"Round","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0790","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.pain.2011.01.051","article-title":"Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial","volume":"152","author":"Rowbotham","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0795","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/B978-0-444-64074-1.00041-0","article-title":"Consequences of perioperative hypothermia","volume":"157","author":"Ruetzler","year":"2018","journal-title":"Handbook of Clinical Neurology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0800","doi-asserted-by":"crossref","first-page":"12797","DOI":"10.1523\/JNEUROSCI.2324-07.2007","article-title":"Uncoupling proton activation of vanilloid receptor TRPV1","volume":"27","author":"Ryu","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0805","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/23328940.2017.1315478","article-title":"Evolutionary tuning of TRPA1 and TRPV1 thermal and chemical sensitivity in vertebrates","volume":"4","author":"Saito","year":"2017","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0810","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0014-4886(88)90057-X","article-title":"Hepatic portal injection of glucose elevates efferent sympathetic discharges of interscapular brown adipose tissue","volume":"101","author":"Sakaguchi","year":"1988","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0815","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0306-4522(01)00373-6","article-title":"The distribution and regulation of vanilloid receptor VR1 and VR1 5\u2019 splice variant RNA expression in rat","volume":"107","author":"Sanchez","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0820","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36372","article-title":"Irreversible temperature gating in trpv1 sheds light on channel activation","volume":"7","author":"Sanchez-Moreno","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0830","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2125.2012.04377.x","article-title":"An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin","volume":"75","author":"Schaffler","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0835","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00421-010-1791-1","article-title":"Skin temperature as a thermal controller of exercise intensity","volume":"111","author":"Schlader","year":"2011","journal-title":"European Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0840","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/23328940.2017.1319453","article-title":"Turning up the heat on surgical cold","volume":"4","author":"Schmidt","year":"2017","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0850","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1086\/649964","article-title":"Plasticity of oxidative metabolism in variable climates: molecular mechanisms","volume":"83","author":"Seebacher","year":"2010","journal-title":"Physiological and Biochemical Zoology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0855","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1124\/jpet.105.084277","article-title":"5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro","volume":"314","author":"Shimizu","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0860","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41594-018-0108-7","article-title":"Structure and gating mechanism of the transient receptor potential channel TRPV3","volume":"25","author":"Singh","year":"2018","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0865","first-page":"A6339","article-title":"TRPV1 antagonism with XEN-D0501 in chronic obstructive pulmonary disease: Translation from pre-clinical model to clinical trial","volume":"195","author":"Smith","year":"2017","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0870","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-00636-4","article-title":"TRPV1 temperature activation is specifically sensitive to strong decreases in amino acid hydrophobicity","volume":"7","author":"Sosa-Pagan","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0880","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1523\/JNEUROSCI.1483-07.2007","article-title":"Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors","volume":"27","author":"Steiner","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0885","series-title":"Anesthetic Pharmacology: Basic Principles and Clinical Practice","first-page":"648","article-title":"Sympathomimetic and sympatholytic drugs","author":"Stowe","year":"2013"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0890","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.lfs.2017.12.024","article-title":"Activation of the capsaicin-receptor TRPV1 by the acetaminophen metabolite N-arachidonoylaminophenol results in cytotoxicity","volume":"194","author":"Stueber","year":"2018","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0905","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/jm0495071","article-title":"Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist","volume":"48","author":"Swanson","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0910","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0306-4522(89)90269-8","article-title":"Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper","volume":"30","author":"Szallasi","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0915","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0031-6997(24)01403-0","article-title":"Vanilloid (capsaicin) receptors and mechanisms","volume":"51","author":"Szallasi","year":"1999","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0920","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/23328940.2015.1048928","article-title":"Effect of capsaicin on thermoregulation: an update with new aspects","volume":"2","author":"Szolcsanyi","year":"2015","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0925","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1021\/jm500818a","volume":"57","author":"Tafesse","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0935","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1152\/ajplegacy.1972.222.1.114","article-title":"Heat storage in running antelopes: Independence of brain and body temperatures","volume":"222","author":"Taylor","year":"1972","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0945","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nature26137","article-title":"A TRP channel trio mediates acute noxious heat sensing","volume":"555","author":"Vandewauw","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0955","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/978-3-319-05161-1_1","article-title":"TRP channels and thermosensation","volume":"223","author":"Voets","year":"2014","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0960","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature02732","article-title":"The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels","volume":"430","author":"Voets","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0965","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1021\/jm500916t","article-title":"Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)ur ea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacy","volume":"57","author":"Voight","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0970","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrn3784","article-title":"Peripheral thermosensation in mammals","volume":"15","author":"Vriens","year":"2014","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0985","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4161\/cc.11.2.18772","article-title":"Aging reverses the role of the transient receptor potential vanilloid-1 channel in systemic inflammation from anti-inflammatory to proinflammatory","volume":"11","author":"Wanner","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0990","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/jpet.110.175570","article-title":"Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect","volume":"336","author":"Watabiki","year":"2011","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0995","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1248\/bpb.34.1105","article-title":"Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain","volume":"34","author":"Watabiki","year":"2011","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1000","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.brainresrev.2008.12.006","article-title":"Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks","volume":"60","author":"Wong","year":"2009","journal-title":"Brain Research Reviews"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1005","doi-asserted-by":"crossref","first-page":"8710","DOI":"10.1523\/JNEUROSCI.6323-09.2010","article-title":"17-Beta-estradiol enhanced allodynia of inflammatory temporomandibular joint through upregulation of hippocampal TRPV1 in ovariectomized rats","volume":"30","author":"Wu","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1010","first-page":"E3657","article-title":"Rational design and validation of a vanilloid-sensitive TRPV2 ion channel","volume":"113","author":"Yang","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1015","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nchembio.1835","article-title":"Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel","volume":"11","author":"Yang","year":"2015","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1020","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1038\/s41467-018-05339-6","article-title":"The conformational wave in capsaicin activation of transient receptor potential vanilloid 1 ion channel","volume":"9","author":"Yang","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13238-016-0353-7","article-title":"Understand spiciness: mechanism of TRPV1 channel activation by capsaicin","volume":"8","author":"Yang","year":"2017","journal-title":"Protein & Cell"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1030","doi-asserted-by":"crossref","first-page":"F1351","DOI":"10.1152\/ajprenal.00695.2009","article-title":"Functional roles of TRPV1 channels in lower urinary tract irritated by acetic acid: in vivo evaluations of the sex difference in decerebrate unanesthetized mice","volume":"298","author":"Yoshiyama","year":"2010","journal-title":"American Journal of Physiology \u2013 Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1035","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16409","article-title":"Engineering vanilloid-sensitivity into the rat TRPV2 channel","volume":"5","author":"Zhang","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1040","first-page":"E317","article-title":"Heat activation is intrinsic to the pore domain of TRPV1","volume":"115","author":"Zhang","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107474_bb1045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/23328940.2019.1578634","article-title":"Heat activation mechanism of TRPV1: new insights from molecular dynamics simulation","volume":"6","author":"Zheng","year":"2019","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0025","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/sj.bjp.0705387","article-title":"Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists","volume":"139","author":"Appendino","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nbd.2018.08.004","article-title":"Vagal TRPV1 activation exacerbates thermal hyperpnea and increases susceptibility to experimental febrile seizures in immature rats","volume":"119","author":"Barrett","year":"2018","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1476-5381.1992.tb12781.x","article-title":"Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin","volume":"107","author":"Bevan","year":"1992","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2004.07.058","article-title":"Cloning and pharmacological characterization of mouse TRPV1","volume":"370","author":"Correll","year":"2004","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0165","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1476-5381.1991.tb12547.x","article-title":"Selective antagonism of capsaicin by capsazepine: evidence for a spinal receptor site in capsaicin-induced antinociception","volume":"104","author":"Dickenson","year":"1991","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0185","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/jpet.105.084103","article-title":"A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid","volume":"314","author":"El Kouhen","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0255","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.104.079855","article-title":"AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties","volume":"313","author":"Gavva","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejphar.2005.05.002","article-title":"Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat","volume":"517","author":"Jakab","year":"2005","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0365","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/mol.106.023945","article-title":"Functional mapping of the transient receptor potential vanilloid 1 intracellular binding site","volume":"70","author":"Johnson","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0380","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1211\/jpp.58.4.0008","article-title":"Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin","volume":"58","author":"Kanai","year":"2006","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0385","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neuropharm.2005.05.003","article-title":"Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats","volume":"49","author":"Kanai","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0395","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/annrheumdis-2013-203413","article-title":"Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain","volume":"74","author":"Kelly","year":"2015","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0415","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1152\/jn.1999.82.6.2853","article-title":"Inhibition of rapid heat responses in nociceptive primary sensory neurons of rats by vanilloid receptor antagonists","volume":"82","author":"Kirschstein","year":"1999","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0420","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/jpet.112.194027","article-title":"Pharmacological characterization of (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyrid in-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide (JTS-653), a novel transient receptor potential vanilloid 1 antagonist","volume":"342","author":"Kitagawa","year":"2012","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0480","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2011.05.001","article-title":"Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl-(4-trifluoromethyl-phenyl) -amine (JNJ-39729209) as a novel TRPV1 antagonist","volume":"663","author":"Maher","year":"2011","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0485","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.bjp.0707145","article-title":"Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors","volume":"150","author":"Maione","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0525","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2008.07.063","article-title":"Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia","volume":"596","author":"McDonald","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0595","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.112.191932","volume":"342","author":"Nash","year":"2012","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0610","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1744-8069-1-28","article-title":"Acidification of rat TRPV1 alters the kinetics of capsaicin responses","volume":"1","author":"Neelands","year":"2005","journal-title":"Molecular Pain"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0625","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/jm070189q","article-title":"Novel vanilloid receptor-1 antagonists: 1. conformationally restricted analogues of trans-cinnamides","volume":"50","author":"Norman","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0675","doi-asserted-by":"crossref","first-page":"39663","DOI":"10.1074\/jbc.M111.273581","article-title":"The chimeric approach reveals that differences in the TRPV1 pore domain determine species-specific sensitivity to block of heat activation","volume":"286","author":"Papakosta","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0680","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0960-894X(02)00887-9","article-title":"Synthesis of 2-substituted-pyrrolidinethiourea derivatives and their antagonist effect on vanilloid receptor","volume":"13","author":"Park","year":"2003","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0685","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1021\/acs.jmedchem.5b00132","article-title":"Benzo[d]imidazole transient receptor potential vanilloid 1 antagonists for the treatment of pain: discovery of trans-2-(2-{2-[2-(4-trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)- propan-2-ol (mavatrep)","volume":"58","author":"Parsons","year":"2015","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0695","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ph12010019","article-title":"TRPV1 inhibits the ventilatory response to hypoxia in adult rats, but not the CO(2)-drive to breathe","volume":"12","author":"Patrone","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0720","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/sj.bjp.0705711","article-title":"Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide","volume":"141","author":"Price","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0740","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bjp.0705110","article-title":"Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin","volume":"138","author":"Rigoni","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0825","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0028-3908(02)00122-3","article-title":"Cloning and functional characterization of the guinea pig vanilloid receptor 1","volume":"43","author":"Savidge","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0845","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1124\/jpet.102.040394","article-title":"Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin","volume":"303","author":"Seabrook","year":"2002","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0875","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1113\/jphysiol.2010.202465","article-title":"The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors","volume":"589","author":"Steiner","year":"2011","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0895","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1016\/j.bmcl.2003.09.024","article-title":"Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effects","volume":"13","author":"Suh","year":"2003","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0900","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/jpet.108.138511","article-title":"(R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo","volume":"326","author":"Surowy","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0930","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1021\/jm7014638","article-title":"Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists","volume":"51","author":"Tamayo","year":"2008","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0940","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1124\/jpet.102.045674","article-title":"N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties","volume":"306","author":"Valenzano","year":"2003","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0950","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neulet.2005.05.015","article-title":"Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat","volume":"385","author":"Varga","year":"2005","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0975","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/jm070191h","article-title":"Novel vanilloid receptor-1 antagonists: 3. the identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties","volume":"50","author":"Wang","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107474_bb0980","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1016\/j.bmcl.2007.09.080","article-title":"Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility","volume":"17","author":"Wang","year":"2007","journal-title":"Bioorganic & Medicinal Chemistry Letters"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820300024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820300024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:08:59Z","timestamp":1759010939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820300024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":209,"alternative-id":["S0163725820300024"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107474","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107474"}}